Clinical Trials Browser

Terminated × Idarubicin × Myeloid × Clear all

NCT00023920 2013-01-23

Bevacizumab, Idarubicin, and Cytarabine in Treating Patients With Blast Phase Chronic Myelogenous Leukemia

Phase 2 Terminated

MyeloidOther hematologic neoplasm

Blast Crisis, Leukemia, Myelogenous, Chronic, BCR-ABL Positive